Loader

Pathways

PathWhiz ID Pathway Meta Data

PW127970

Pw127970 View Pathway
drug action

Paroxetine Mechanism of Action Action Pathway (New)

Homo sapiens
Paroxetine is a selective serotonin reuptake inhibitor. It is used to manage major depressive disorder, panic disorder, OCD, social phobia, generalized anxiety disorder, the vasomotor symptoms of menopause, and premenstrual dysphoric disorder. Paroxetine selectively binds to the sodium dependent serotonin transporter (SERT) and blocks the recycling of serotonin from the synapse. As serotonin accumulates it enhances the serotonergic function of the 5-hydroxytryptamine 1A receptor leading to decreased anxiety and depressive moods. Lower serotonin concentrations in a depressed brain induces the upregulation of serotonergic receptors therefore by increasing the concentration of serotonin in the synapse, paroxetine in turn induces down regulation of the former upregulated serotonin receptors thereby restoring receptor concentration. Paroxetine has demonstrated a stronger inhibitory effect on serotonin reuptake than other members of the same drug class, including Citalopram, Fluoxetine, and Fluvoxamine.

PW128109

Pw128109 View Pathway
drug action

Paroxetine Mechanism of Action Action Pathway New

Homo sapiens
Paroxetine is a selective serotonin reuptake inhibitor. It is used to manage major depressive disorder, panic disorder, OCD, social phobia, generalized anxiety disorder, the vasomotor symptoms of menopause, and premenstrual dysphoric disorder. Paroxetine selectively binds to the sodium dependent serotonin transporter (SERT) and blocks the recycling of serotonin from the synapse. As serotonin accumulates it enhances the serotonergic function of the 5-hydroxytryptamine 1A receptor leading to decreased anxiety and depressive moods. Lower serotonin concentrations in a depressed brain induces the upregulation of serotonergic receptors therefore by increasing the concentration of serotonin in the synapse, paroxetine in turn induces down regulation of the former upregulated serotonin receptors thereby restoring receptor concentration. Paroxetine has demonstrated a stronger inhibitory effect on serotonin reuptake than other members of the same drug class, including Citalopram, Fluoxetine, and Fluvoxamine.

PW176397

Pw176397 View Pathway
metabolic

Paroxetine Predicted Metabolism Pathway

Homo sapiens
Metabolites of Paroxetine are predicted with biotransformer.

PW146578

Pw146578 View Pathway
drug action

Parthenolide Drug Metabolism Action Pathway

Homo sapiens

PW145731

Pw145731 View Pathway
drug action

Pasireotide Drug Metabolism Action Pathway

Homo sapiens

PW146718

Pw146718 View Pathway
drug action

Patent Blue Drug Metabolism Action Pathway

Homo sapiens

PW176475

Pw176475 View Pathway
metabolic

Patent Blue Predicted Metabolism Pathway

Homo sapiens
Metabolites of Patent Blue are predicted with biotransformer.

PW122450

Pw122450 View Pathway
physiological

Pathway

Homo sapiens

PW124347

Pw124347 View Pathway
disease

Pathway in cancer

Homo sapiens

PW000974

Pw000974 View Pathway
metabolic

PathWhiz Pt.2 - Video Learning Tutorials (Skeleton)

Homo sapiens